MTOR and lung cancer: Along with other groups, we have have found that antroquinonol inhibits lung cancer and liver cancer cells by modulating the AMP-activated protein kinase (AMPK) or phosphatidylinositol-3-kinase (PI3K)/ mammalian target of rapamycin (mTOR) pathways [154, 155].